Callos Andrew sold CYTK

March 18, 2026 · Form 4 insider transaction

Callos Andrew sold 1,930 shares of Cytokinetics, Incorporated at $62.07 per share, a transaction worth $119.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.